Social VC Investments
Healthtech startup Niramai gets CDC funding for Covid-19 screening test
Bengaluru-based Niramai Health Analytix, a deep-tech health startup offering AI and thermal-imaging-based breast cancer screening tests, has raised research funding from CDC-UK for its new thermal-screening solution. Niramai is already an investee of Pi Ventures, a fund backed by CDC Group, the UK's development finance institution and impact investor. Niramai FeverTest is a smart software that enables screening for Covid-19 symptoms in public places, using computer vision and AI to analyze and monitor crowd compliance to pandemic guidelines. Analysing infrared and visual cameras across multiple hospitals, corporate offices and public places, the software offers an automated screening solution that can help control the community spread of the disease.
From the Venture Intelligence PE-VC Deal Database: Between Mar-17 and Nov-18, Niramai raised over $7-M from Dream Incubator, Beenext, Pi Ventures, Axilor Ventures, Ankur Capital, Kris Gopalakrishnan and others. (Subscribers to the database can login to view the valuation, deal structuring and other transaction details.)
Want to receive such news items in your inbox? Click Here to sign up for a trial.
